Proposed Data Collection Submitted for Public Comment and Recommendations, 54580-54581 [2016-19461]

Download as PDF 54580 Federal Register / Vol. 81, No. 158 / Tuesday, August 16, 2016 / Notices Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2016–19460 Filed 8–15–16; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. CDC–2016–0083; 60Day–16– 16AWM] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention, Department of Health and Human Services. ACTION: Notice with comment period. AGENCY: Centers for Disease Control and Prevention as part of its continuing efforts to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies to take this opportunity to comment on this proposed information collections, as required by the Paperwork Reduction Act of 1995. This notice invites comment on the Executive and Scientific Resources Office Access Management System (EAMTS). EAMTS is designed to house all Guest Researcher & ORISE program packets, Appointment Mechanism Determination Forms, and Title 42 Fellowship Immigration information in one central location on the Human Resources Office SharePoint Server. DATES: Written comments must be received on or before October 17, 2016. ADDRESSES: You may submit comments, identified by Docket No. CDC–2016– 0083 by any of the following methods: Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. Mail: Jeffrey M. Zirger, Acting Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS– D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. All relevant comments received will be posted without change to Regulations.gov, including any personal information provided. For access to the docket to read background documents or comments received, go to Regulations.gov. asabaliauskas on DSK3SPTVN1PROD with NOTICES SUMMARY: VerDate Sep<11>2014 18:36 Aug 15, 2016 Jkt 238001 Note: All public comment should be submitted through the Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact the Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS–D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology; and (e) estimates of capital or start-up costs and costs of operation, maintenance, and purchase of services to provide information. Burden means the total time, effort, or financial resources expended by persons to generate, maintain, retain, disclose or provide information to or for a Federal agency. This includes the time needed to review instructions; to develop, acquire, install and utilize technology and systems for the purpose of collecting, validating and verifying information, processing and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information, to search data sources, to complete and review PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 the collection of information; and to transmit or otherwise disclose the information. Proposed Project Data Management for Executive and Scientific Resources Access Management Tracking System—New— Executive and Scientific Resource Office (ESRO), Centers for Disease Control and Prevention (CDC). Background and Brief Description ESRO seeks to submit and information collection request for approval of information collections through its ESRO Access Management Tracking System (EAMTS). This system will automate current manual processes for programs managed by ESRO. This new process will provide users a single, integrated location to allow for collaboration, faster processing between the programs and ESRO and a better onboarding experience for potential fellows. EAMTS will support users by providing a single, integrated location for enterprise content management, manage documents and records by using workflows an information rights management. This business process will allow ESRO to design forms that are accessible in SharePoint through a Web Browser. Team members will be able to access critical business information, analyze and view data, and publish reports to make more informed decisions. EAMTS will allow CIO’s to submit digital packets including Guest Researcher, ORISE, Title 42 Fellowship Visa request (portion of CDC 0.1475) and Appointment Mechanism Determination Request Form (CDC 0.4601). CIO’s can upload supplemental documentation as an attachment to each application, electronically track and monitor status of application, digitally sign forms and requests, receive case determinations quickly and accurately, and track the Visa status of Title 42 Fellowship requests that require Visa assistance from the Human Resources Office. EAMTS is developed in SharePoint for CDC’s Centers/Institutes/Offices (CIO) to submit required information for all of Executive and Scientific Resource Office’s managed programs and for these CIO’s to effectively and efficiently digitally review this information. Data is managed and maintained by appropriate CIO Staff with ground and form level permission. Permissions to EAMTS are required to access the lists, forms, and document library. This includes entering data, E:\FR\FM\16AUN1.SGM 16AUN1 54581 Federal Register / Vol. 81, No. 158 / Tuesday, August 16, 2016 / Notices clearing/approving forms, processing forms, and acknowledging data entered. The total estimated annualized burden hours for all respondents are 1,280. There are no costs to respondents other than their time. CDC will seek a three-year approval from OMB. ESTIMATED ANNUALIZED BURDEN HOURS Type of respondents Initiator/C/I/O Initiator/C/I/O Initiator/C/I/O Initiator/C/I/O Number of respondents Form name Number of responses per CIO Average burden per response (in hours) Total burden (in hours) ..................................... ..................................... ..................................... ..................................... CDC 0.4601 ..................................... CDC 0.410A ..................................... CDC 0.410B ..................................... Section C of the CDC 0.1475 .......... 64 64 64 64 5 5 5 5 1 1 1 1 320 320 320 320 Totals ......................................... ........................................................... ........................ ........................ ........................ 1,280 Leroy A. Richardson, Chief, Information Collection Review Office, Office of Scientific Integrity, Office of the Associate Director for Science, Office of the Director, Centers for Disease Control and Prevention. [FR Doc. 2016–19461 Filed 8–15–16; 8:45 am] Bethesda, MD 20892–9823, (240) 669–5069, lrust@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: August 10, 2016. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2016–19417 Filed 8–15–16; 8:45 am] National Institutes of Health BILLING CODE 4140–01–P National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting DEPARTMENT OF HEALTH AND HUMAN SERVICES asabaliauskas on DSK3SPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Clinical Trial Implementation Cooperative Agreement (U01). Date: September 22, 2016. Time: 10:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Room 3F100, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Lynn Rust, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, Room 3G42A, National Institutes of Health/ NIAID, 5601 Fishers Lane, MSC 9823, VerDate Sep<11>2014 18:36 Aug 15, 2016 Jkt 238001 National Institutes of Health Prospective Grant of Start-Up Exclusive Evaluation Option License Agreement: Small Molecule Therapeutic Compounds Encompassed Within the Licensed Patent Rights for the Treatment of Thioesterase Deficiency Disorder AGENCY: National Institutes of Health, HHS. ACTION: Notice. This notice, in accordance with 35 U.S.C. 209 and 37 CFR part 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of a Start-Up Exclusive Evaluation Option License Agreement to practice the inventions embodied in the following Patent Applications to Circumvent Pharmaceuticals Inc. (‘‘Circumvent’’) located in Pasadena, California, USA: SUMMARY: Intellectual Property United States Provisional Patent Application No. 61/473,692, filed April 8, 2011, titled ‘‘Small molecule therapeutic compounds targeting thioesterase deficiency disorders and methods of using the same’’ [HHS PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 Reference No. E–157–2011/0–US–01], status: Expired; International Patent Application No. PCT/US2012/32772 filed April 9, 2012 titled ‘‘Small molecule therapeutic compounds targeting thioesterase deficiency disorders and methods of using the same’’ [HHS Reference No. E– 157–2011/0–PCT–02], status: Converted; European Patent Application No. 12716889.6, filed November 7, 2013, titled ‘‘Small molecule therapeutic compounds targeting thioesterase deficiency disorders and methods of using the same’’ [HHS Reference No. E– 157–2011/0–EP–03], status: Pending; and United States Patent Application No. 14/110,393, filed October 7, 2013, titled ‘‘Small molecule therapeutic compounds targeting thioesterase deficiency disorders and methods of using the same’’ [HHS Reference No. E– 157–2011/0–US–04], status: Pending. The patent rights in these inventions have been assigned and/or exclusively licensed to the government of the United States of America. The territory of the prospective StartUp Exclusive Evaluation Option License Agreement may be worldwide and the field of use may be limited to: ‘‘Small molecule therapeutic compounds encompassed within the Licensed Patent Rights for the treatment of thioesterase deficiency disorders’’ Upon the expiration or termination of the Start-up Exclusive Evaluation Option License Agreement, Circumvent will have the exclusive right to execute a Start-Up Exclusive Patent License Agreement which will supersede and replace the Start-up Exclusive Evaluation Option License Agreement, with no greater field of use and territory than granted in the Start-up Exclusive Evaluation Option License Agreement. DATES: Only written comments and/or applications for a license which are received by the NIH Office of E:\FR\FM\16AUN1.SGM 16AUN1

Agencies

[Federal Register Volume 81, Number 158 (Tuesday, August 16, 2016)]
[Notices]
[Pages 54580-54581]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-19461]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2016-0083; 60Day-16-16AWM]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention, Department of 
Health and Human Services.

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: Centers for Disease Control and Prevention as part of its 
continuing efforts to reduce public burden and maximize the utility of 
government information, invites the general public and other Federal 
agencies to take this opportunity to comment on this proposed 
information collections, as required by the Paperwork Reduction Act of 
1995. This notice invites comment on the Executive and Scientific 
Resources Office Access Management System (EAMTS). EAMTS is designed to 
house all Guest Researcher & ORISE program packets, Appointment 
Mechanism Determination Forms, and Title 42 Fellowship Immigration 
information in one central location on the Human Resources Office 
SharePoint Server.

DATES: Written comments must be received on or before October 17, 2016.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2016-
0083 by any of the following methods: Federal eRulemaking Portal: 
Regulations.gov. Follow the instructions for submitting comments.
    Mail: Jeffrey M. Zirger, Acting Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE., MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. All relevant comments received will be posted 
without change to Regulations.gov, including any personal information 
provided. For access to the docket to read background documents or 
comments received, go to Regulations.gov.

    Note: All public comment should be submitted through the Federal 
eRulemaking portal (Regulations.gov) or by U.S. mail to the address 
listed above.


FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact the Information Collection Review Office, 
Centers for Disease Control and Prevention, 1600 Clifton Road NE., MS-
D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
Federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; (d) ways to 
minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services 
to provide information. Burden means the total time, effort, or 
financial resources expended by persons to generate, maintain, retain, 
disclose or provide information to or for a Federal agency. This 
includes the time needed to review instructions; to develop, acquire, 
install and utilize technology and systems for the purpose of 
collecting, validating and verifying information, processing and 
maintaining information, and disclosing and providing information; to 
train personnel and to be able to respond to a collection of 
information, to search data sources, to complete and review the 
collection of information; and to transmit or otherwise disclose the 
information.

Proposed Project

    Data Management for Executive and Scientific Resources Access 
Management Tracking System--New--Executive and Scientific Resource 
Office (ESRO), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    ESRO seeks to submit and information collection request for 
approval of information collections through its ESRO Access Management 
Tracking System (EAMTS). This system will automate current manual 
processes for programs managed by ESRO. This new process will provide 
users a single, integrated location to allow for collaboration, faster 
processing between the programs and ESRO and a better onboarding 
experience for potential fellows.
    EAMTS will support users by providing a single, integrated location 
for enterprise content management, manage documents and records by 
using workflows an information rights management. This business process 
will allow ESRO to design forms that are accessible in SharePoint 
through a Web Browser. Team members will be able to access critical 
business information, analyze and view data, and publish reports to 
make more informed decisions.
    EAMTS will allow CIO's to submit digital packets including Guest 
Researcher, ORISE, Title 42 Fellowship Visa request (portion of CDC 
0.1475) and Appointment Mechanism Determination Request Form (CDC 
0.4601). CIO's can upload supplemental documentation as an attachment 
to each application, electronically track and monitor status of 
application, digitally sign forms and requests, receive case 
determinations quickly and accurately, and track the Visa status of 
Title 42 Fellowship requests that require Visa assistance from the 
Human Resources Office.
    EAMTS is developed in SharePoint for CDC's Centers/Institutes/
Offices (CIO) to submit required information for all of Executive and 
Scientific Resource Office's managed programs and for these CIO's to 
effectively and efficiently digitally review this information. Data is 
managed and maintained by appropriate CIO Staff with ground and form 
level permission.
    Permissions to EAMTS are required to access the lists, forms, and 
document library. This includes entering data,

[[Page 54581]]

clearing/approving forms, processing forms, and acknowledging data 
entered.
    The total estimated annualized burden hours for all respondents are 
1,280. There are no costs to respondents other than their time. CDC 
will seek a three-year approval from OMB.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondents           Form name        Number of     responses per   per response    Total burden
                                                    respondents         CIO         (in hours)      (in hours)
----------------------------------------------------------------------------------------------------------------
Initiator/C/I/O...............  CDC 0.4601......              64               5               1             320
Initiator/C/I/O...............  CDC 0.410A......              64               5               1             320
Initiator/C/I/O...............  CDC 0.410B......              64               5               1             320
Initiator/C/I/O...............  Section C of the              64               5               1             320
                                 CDC 0.1475.
                                                 ---------------------------------------------------------------
    Totals....................  ................  ..............  ..............  ..............           1,280
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-19461 Filed 8-15-16; 8:45 am]
 BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.